Misoprostol Versus Dilapan-S for Cervical Preparation

Completed · Not applicable

Conditions studied: Cervical Ripening

In brief

The purpose of this study is to compare the dilatory effect of 400 mcg of buccally administered misoprostol to one Dilapan-S rod placed 3-4 hours before abortion by dilation and evacuation in women who are 12 weeks 0 days to 15 weeks 0 days gestation.

Key facts

Study ID

NCT00835731

Run by

Planned Parenthood League of Massachusetts

People needed

125

Starts

2009-01-01

Expected to finish

2011-12-01

Last updated by the study team

2017-10-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• medically eligible for dilation and evacuation at Planned Parenthood League of Massachusetts
• gestational age 12 weeks 0 days to 15 weeks 0 days as evaluated by ultrasound
• proficient in English or Spanish
• agreeing to study procedures, including randomization and surveys regarding demographics, medical and gynecological history, and assessments of pain and satisfaction

You may not qualify if…

• less than 18 years old
• cervical or uterine anomaly that the research physician deems may affect the difficulty of dilation or the abortion procedure
• inflammatory bowel disease
• contraindication to misoprostol use
• known intolerance or allergy to misoprostol or Dilapan-S
• inability to give informed consent

Where it is running

• Planned Parenthood League of Massachusetts — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.